Market Definition:
Lung cancer screening is a type of medical screening that is used to look for signs of lung cancer in people who are at high risk for the disease. The goal of lung cancer screening is to find lung cancer early when it is more likely to be curable.
There are two main types of lung cancer screening: low-dose computed tomography (LDCT) and sputum cytology. LDCT is a type of X-ray that uses a lower dose of radiation than a standard X-ray. Sputum cytology is a type of test that looks at a person’s sputum (mucus that is coughed up from the lungs) under a microscope to look for abnormal cells that may be cancerous.
To Know More: https://www.globalinsightservices.com/reports/lung-cancer-screening-market/
Market Outlook:
Lung cancer screening technology is constantly evolving, and new trends are emerging all the time. Here are some of the key trends in this field:
1. New imaging technologies: With the advent of new imaging technologies such as PET/CT, it is now possible to detect very small lesions that were previously undetectable. This means that more people can be screened for lung cancer, and more early-stage cancers can be caught.
2. Low-dose CT: Low-dose CT is becoming more widely available, and it is becoming the preferred method of screening for many people. This is because it is less invasive than other methods and it can detect very small lesions.
3. Sputum cytology: Sputum cytology is a new method of screening for lung cancer that is less invasive than other methods. It involves taking a sample of sputum (mucus coughed up from the lungs) and looking at it under a microscope.
Key Drivers
There are several key drivers of the lung cancer screening market.
First, the high incidence and mortality of lung cancer make it a significant public health burden. In the United States, lung cancer is the leading cause of cancer death, accounting for more than 150,000 deaths each year.
Second, the development of new and improved screening technologies has made lung cancer screening more feasible and effective.
Finally, the cost of lung cancer screening has been declining in recent years. This is due to the development of new technologies that are more affordable and the increasing use of insurance coverage for screening services.
Restraints & Challenges
There are a number of key restraints and challenges associated with lung cancer screening.
First, the accuracy of screening tests is often limited, meaning that many people who are screened will not actually have lung cancer. This can lead to unnecessary anxiety and stress for patients, as well as unnecessary costs.
Second, even when lung cancer is detected early, it is often very difficult to treat. This is due to the fact that lung cancer is often very aggressive and spreads quickly. As a result, many people who are diagnosed with lung cancer will ultimately die from the disease.
Finally, lung cancer screening is often not covered by insurance, meaning that many people will have to pay out of pocket for the costs of screening.
Request Sample: https://www.globalinsightservices.com/request-sample/GIS21959
Research Objectives:
• Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region
• Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
• Identify factors influencing market growth and challenges, opportunities, drivers and restraints
• Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
• Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
• Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
• To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.
• Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives
Request Customization: https://www.globalinsightservices.com/request-customization/GIS21959
Market Segments
The lung cancer screening market is segmented by cancer type, end-user, and region. By cancer type, the market is classified into non-small cell lung cancer, and small cell lung cancer. Based on end-user, it is bifurcated into hospitals, clinics, and diagnostic centers. Region-wise, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
Key Players
The global lung cancer screening market includes players such as Abbott Diagnostics, Dr. Lal PathLabs, F. Hoffmann-La Roche AG, Illumina Inc, Myriad Genetics Inc, NanoString Technologies, NeoGenomics Laboratories Inc, PlexBio Co Ltd, Qiagen GmbH, Quest Diagnostics, and others.
Request Discounted Pricing: https://www.globalinsightservices.com/request-special-pricing/GIS21959
Research Scope:
• Scope – Highlights, Trends, Insights. Attractiveness, Forecast
• Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others
• Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain
• Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
• Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
• Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis
Buy your copy here: https://www.globalinsightservices.com/checkout/single_user/GIS21959
About Us:
With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Infographic excel data pack, easy to analyze big data
• Robust and transparent research methodology
• Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.